U.S. federal trademark · Serial No. 97492265
Anti-cancer preparations, namely, biological preparations for developing T-cell based immunotherapy by building a series of proprietary tumor infiltrating lymphocyte; Anti-cancer preparations, namely, medical cell function activating drugs for developing T-cell based immunotherapy by building a series of proprietary tumor infiltrating lymphocyte; anti-cancer preparations in the nature of biological agents for treating cancer, namely, for treatment of solid tumor cancers by tumor infiltrating lymphocyte (TIL) therapy; Tumor suppressing agents for treating cancer, namely, for treatment of solid tumor cancers by TIL therapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.